A common pathway for diabetic eye screening: update

Info

Please note that for mobiles we stream the presentation slides and audio of the speaker.

Info

You must login to watch this lecture.

x Mobile version: slides + audio only
-15s 00:00 / 12:32 +15s
Minimise video

Lynne Lacey provides an update on the pathway for screening for diabetic eye disease. She discusses what has changed — such as new surveillance practices and grading definitions — and how different parts of healthcare fit in to the pathway.

This lecture was part of an event called ‘National diabetic eye screening conference 2014: integration — where do I fit in?’ at The Royal Society of Medicine in London. 

Date of lecture: 30th April 2014

This video is available for iPad via Safari

Length: 00:12:32

Error

You must login to watch this lecture.

Error

You must login to watch this lecture.

53:49

Professor Nick Wareham, MRC Epidemiology Unit, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge

CPD Archived View
21:02

Dr Lisa Webber, Consultant Gynaecologist and Specialist in Reproductive Medicine, St Mary's Hospital.

CPD Archived View
27:37

Professor Julie Lovegrove, Deputy Director, Institute for Cardiovascular and Metabolic Research, University of Reading. 

CPD Archived View
29:11

Dr Nicola Bridges, Consultant Paediatric Endocrinologist, Chelsea & Westminster Hospital. 

CPD Archived View
13:43

Dr Breanne Everett, CEO and President, Orpyx, Calgary, Canada.

Free Archived View
29:37

Gordon Rustin, Director of Medical Oncology, East & North Hertfordshire NHS Trust. 

CPD Archived View
19:29

Robert Sherriff, National Operations Director, NHS Screening Programmes, Public Health England. 

View
12:32

Lynne Lacey, Programme, Manager, NHS Diabetic Eye Screening Programme. 

View
12:54

Madeline Johnson, Consultant in Public Health, Regional Quality Assurance Lead North, UK.

View